{"SPADE_UN_14985": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_14985", "Peptide Name": "SARSWW-III(1028-1049)", "Source": "Synthetic construct(derived from SARS-CoV spike protein)", "Family": "Coronaviridae", "Gene": "Not found", "Sequence": "GYHLMSFPQAAPHGVVFLHVTW", "Sequence Length": 22, "UniProt Entry": ["http://www.uniprot.org/uniprot/P11224"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(90% inhibition at ~30 μM,IC50=2 μM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 μM.", "Binding Target": "membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C120H168N30O27S", "Mass": 2494.87, "PI": 7.02, "Net Charge": 3, "Hydrophobicity": 0.48, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "No comments found on DRAMP database", "Literature": [{"Title": "Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein", "Pubmed ID": "16616792", "Reference": "Virus Res. 2006 Sep;120(1-2)146-55.", "Author": "Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16616792"}], "Frequent Amino Acids": "HVA", "Absent Amino Acids": "CDEIKNORU", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 12, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": []}}}